These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26605928)

  • 21. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
    Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
    Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.
    Pasquier E; de Saint-Martin L; Marhic G; Chauleur C; Bohec C; Bretelle F; Lejeune-Saada V; Hannigsberg J; Plu-Bureau G; Cogulet V; Merviel P; Mottier D
    BMJ Open; 2019 Mar; 9(3):e025649. PubMed ID: 30898821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
    Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
    Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.
    Chen H; Fu J; Huang W
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008883. PubMed ID: 27455388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial.
    Okeke Ogwulu CB; Goranitis I; Devall AJ; Cheed V; Gallos ID; Middleton LJ; Harb HM; Williams HM; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Deb S; Duncan WC; Ewer AK; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden M; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Coomarasamy A; Roberts TE
    BJOG; 2020 May; 127(6):757-767. PubMed ID: 32003141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind randomized trial of progesterone to prevent preterm birth in second-trimester bleeding.
    Salim R; Hakim M; Zafran N; Nachum Z; Romano S; Garmi G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1318-1325. PubMed ID: 31087325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.
    Clifford K; Rai R; Watson H; Franks S; Regan L
    BMJ; 1996 Jun; 312(7045):1508-11. PubMed ID: 8646142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception.
    Dhillon-Smith RK; Middleton LJ; Sunner KK; Cheed V; Baker K; Farrell-Carver S; Bender-Atik R; Agrawal R; Bhatia K; Edi-Osagie E; Ghobara T; Gupta P; Jurkovic D; Khalaf Y; MacLean M; McCabe C; Mulbagal K; Nunes N; Overton C; Quenby S; Rai R; Raine-Fenning N; Robinson L; Ross J; Sizer A; Small R; Tan A; Underwood M; Kilby MD; Boelaert K; Daniels J; Thangaratinam S; Chan SY; Coomarasamy A
    N Engl J Med; 2019 Apr; 380(14):1316-1325. PubMed ID: 30907987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM).
    Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J
    Health Technol Assess; 2018 Jun; 22(35):1-304. PubMed ID: 29945711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    van Dijk MM; Vissenberg R; Fliers E; van der Post JAM; van der Hoorn MP; de Weerd S; Kuchenbecker WK; Hoek A; Sikkema JM; Verhoeve HR; Broeze KA; de Koning CH; Verpoest W; Christiansen OB; Koks C; de Bruin JP; Papatsonis DNM; Torrance H; van Wely M; Bisschop PH; Goddijn M
    Lancet Diabetes Endocrinol; 2022 May; 10(5):322-329. PubMed ID: 35298917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone supplementation in women with otherwise unexplained recurrent miscarriages.
    Hussain M; El-Hakim S; Cahill DJ
    J Hum Reprod Sci; 2012 Sep; 5(3):248-51. PubMed ID: 23533097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
    Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
    Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial.
    Devine K; Richter KS; Jahandideh S; Widra EA; McKeeby JL
    Fertil Steril; 2021 Sep; 116(3):633-643. PubMed ID: 33992421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.